RU98121428A - α-Amylase Mutants - Google Patents
α-Amylase MutantsInfo
- Publication number
- RU98121428A RU98121428A RU98121428/13A RU98121428A RU98121428A RU 98121428 A RU98121428 A RU 98121428A RU 98121428/13 A RU98121428/13 A RU 98121428/13A RU 98121428 A RU98121428 A RU 98121428A RU 98121428 A RU98121428 A RU 98121428A
- Authority
- RU
- Russia
- Prior art keywords
- amylase
- bacillus
- variant
- maternal
- sequence shown
- Prior art date
Links
- 102000004139 alpha-Amylases Human genes 0.000 title claims 32
- 108090000637 alpha-Amylases Proteins 0.000 title claims 32
- 229940024171 alpha-amylase Drugs 0.000 title claims 28
- 102000004190 Enzymes Human genes 0.000 claims 10
- 108090000790 Enzymes Proteins 0.000 claims 10
- 229940088598 Enzyme Drugs 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- 239000003599 detergent Substances 0.000 claims 7
- 230000035772 mutation Effects 0.000 claims 7
- 102200001910 AICDA Y31H Human genes 0.000 claims 6
- 102200144078 BUB1B M15T Human genes 0.000 claims 6
- 102200085943 NR3C1 R23K Human genes 0.000 claims 6
- 102200033500 SPATA1 S29A Human genes 0.000 claims 6
- 102200039443 SPINT4 A30E Human genes 0.000 claims 6
- 102200024726 TRARG1 E34D Human genes 0.000 claims 6
- 102200063269 WDR33 A33S Human genes 0.000 claims 6
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims 5
- 239000000654 additive Substances 0.000 claims 5
- 230000000996 additive Effects 0.000 claims 5
- 229940106157 CELLULASE Drugs 0.000 claims 4
- 108010059892 Cellulase Proteins 0.000 claims 4
- 102000033147 ERVK-25 Human genes 0.000 claims 4
- 229940040461 Lipase Drugs 0.000 claims 4
- 239000004367 Lipase Substances 0.000 claims 4
- 108091005771 Peptidases Proteins 0.000 claims 4
- 229940072417 Peroxidase Drugs 0.000 claims 4
- 102000003992 Peroxidases Human genes 0.000 claims 4
- 108090000437 Peroxidases Proteins 0.000 claims 4
- 239000004365 Protease Substances 0.000 claims 4
- 230000003625 amylolytic Effects 0.000 claims 4
- 239000011575 calcium Substances 0.000 claims 4
- 102000004882 lipase Human genes 0.000 claims 4
- 235000019421 lipase Nutrition 0.000 claims 4
- 108090001060 lipase Proteins 0.000 claims 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims 3
- 241000194108 Bacillus licheniformis Species 0.000 claims 3
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 3
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 3
- 238000004851 dishwashing Methods 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 239000000758 substrate Substances 0.000 claims 3
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 2
- 229910052791 calcium Inorganic materials 0.000 claims 2
- 238000005406 washing Methods 0.000 claims 2
- 241000193752 Bacillus circulans Species 0.000 claims 1
- 229940054340 Bacillus coagulans Drugs 0.000 claims 1
- 241000193749 Bacillus coagulans Species 0.000 claims 1
- 241000193422 Bacillus lentus Species 0.000 claims 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 claims 1
- 240000008371 Bacillus subtilis Species 0.000 claims 1
- 229940075615 Bacillus subtilis Drugs 0.000 claims 1
- 235000014469 Bacillus subtilis Nutrition 0.000 claims 1
- 229940097012 Bacillus thuringiensis Drugs 0.000 claims 1
- 241000193388 Bacillus thuringiensis Species 0.000 claims 1
- 241000193764 Brevibacillus brevis Species 0.000 claims 1
- 102100012510 F11R Human genes 0.000 claims 1
- 101710026483 F11R Proteins 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 101700014927 N190 Proteins 0.000 claims 1
- 241000194109 Paenibacillus lautus Species 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 230000001419 dependent Effects 0.000 claims 1
- 238000009990 desizing Methods 0.000 claims 1
- 230000001747 exhibiting Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 238000002708 random mutagenesis Methods 0.000 claims 1
- 238000003259 recombinant expression Methods 0.000 claims 1
- 102220226382 rs1064794788 Human genes 0.000 claims 1
- 239000004299 sodium benzoate Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000004753 textile Substances 0.000 claims 1
Claims (23)
мутации: A181E,D,Q,N,V; 1201 (основная аминокислота), включающая I201W, F, L; Y203Q; Q9K, L, E; F11R,K,E; E12Q; D100N,L; V101H,R,K,D,E,F; V102A,T; I103H, K; N104R,K,D; H105R,K,D,E,W,F; L196R,K,D,E,F,Y; I212R,K,D,E; L230H,K, I; A232G, H, F, S,V; V233D; K234L,E; I236R,K,N,H,D,E; L241R,K,D,E,F; A260S; W263H; Q264R, D,K,E; N265K,R,D; A269R,K,D,E; L270R,K,H,D,E; V283H,D; F284H; D285N, L; V286R,K,H,D,E; Y290R,E,K; V312R,K,D,E; F323H; D325N; N326K,H,D,L; H327Q, N,E,D,F; Q330L,E; G332D; Q333R,K,H,E,L; S334A,V,T,L,I,D; L335G,A,S,T, N; E336R+R375E; T337D, K; T338D, E; T339D; Q360K,R,E; D365N; или G371D,R; замена в позициях H68, H91, H247, R305, K306, H382, K389, H405, H406, H450 или R483;
мутации: H140Y; H142Y; H159Y; H140D+H142R; H140K+H142D; или H142Y+H156Y;
деления из трех аминокислот в рамках неполной последовательности от T369 до I377, включающая следующие делеции: K370*+G371*+D372* или D372*+S373*+Q374*;
замещение неполной аминокислотной последовательности от T369 до I377 на одну из следующих последовательностей (число последовательности увеличивается слева направо): I-Р-T-H-S-V; I-P-T-H-G-V; I-P-Q-Y-N-I;
замены в позициях R169 или R173, включающие R169I,L,F,T или R173I,L,F,T;
мутации H156D; I201F; I212F; A209L,T; или V208I;
замены в позициях N172, A181, N188, N190, H205, D207, A209, A210, E211, Q264 или N265, включающие N172R,H,K; A181T; N188P; N190L,F; H205C; D207Y; A209L,T,V; A210S; E211Q; Q264A,E,L,K,S,T; N265A,S,T,Y; или Q264S+N265Y;
мутации:
H156Y+A181T+A209V;
H156Y+A181T+N190F+A209V+Q264S;
A1*+N2*+L3V+M15T+R23K+S29A+A30E+Y31H+A33S+E34D+H35I+ H156Y+A181T+A209V;
A1*+N2*+L3V+M15T+R23K+S29A+A30E+Y31H+A33S+E34D+H35I+H156Y+A181T+N190F+A209V; или
A1*+N2*+L3V+M15T+R23K+S29A+A30E+Y31H+A33S+E34D+H35I+H156Y+A181T+N190F+A209V+Q264S.1. A variant of maternal Termamyl-like α-amylase having α-amylase activity and exhibiting a change in at least one of the following properties with respect to said maternal α-amylase: substrate specificity, substrate binding, type of substrate cleavage, thermal stability, profile pH / activity, pH profile / stability, oxidation stability, Ca 2+ -dependent and specific activity; however, this option includes one or more mutations corresponding to one or more of the following mutations in the amino acid sequence shown in SEQ ID No. 2:
mutations: A181E, D, Q, N, V; 1201 (basic amino acid) including I201W, F, L; Y203Q; Q9K, L, E; F11R, K, E; E12Q; D100N, L; V101H, R, K, D, E, F; V102A, T; I103H, K; N104R, K, D; H105R, K, D, E, W, F; L196R, K, D, E, F, Y; I212R, K, D, E; L230H, K, I; A232G, H, F, S, V; V233D; K234L, E; I236R, K, N, H, D, E; L241R, K, D, E, F; A260S; W263H; Q264R, D, K, E; N265K, R, D; A269R, K, D, E; L270R, K, H, D, E; V283H, D; F284H; D285N, L; V286R, K, H, D, E; Y290R, E, K; V312R, K, D, E; F323H; D325N; N326K, H, D, L; H327Q, N, E, D, F; Q330L, E; G332D; Q333R, K, H, E, L; S334A, V, T, L, I, D; L335G, A, S, T, N; E336R + R375E; T337D, K; T338D, E; T339D; Q360K, R, E; D365N; or G371D, R; replacement in positions H68, H91, H247, R305, K306, H382, K389, H405, H406, H450 or R483;
mutations: H140Y; H142Y; H159Y; H140D + H142R; H140K + H142D; or H142Y + H156Y;
division of three amino acids in an incomplete sequence from T369 to I377, including the following deletions: K370 * + G371 * + D372 * or D372 * + S373 * + Q374 *;
substitution of an incomplete amino acid sequence from T369 to I377 with one of the following sequences (the number of the sequence increases from left to right): I-P-THSV; IPTHGV; IPQYNI;
replacements at R169 or R173, including R169I, L, F, T or R173I, L, F, T;
mutations H156D; I201F; I212F; A209L, T; or V208I;
replacements at positions N172, A181, N188, N190, H205, D207, A209, A210, E211, Q264 or N265, including N172R, H, K; A181T; N188P; N190L, F; H205C; D207Y; A209L, T, V; A210S; E211Q; Q264A, E, L, K, S, T; N265A, S, T, Y; or Q264S + N265Y;
mutations:
H156Y + A181T + A209V;
H156Y + A181T + N190F + A209V + Q264S;
A1 * + N2 * + L3V + M15T + R23K + S29A + A30E + Y31H + A33S + E34D + H35I + H156Y + A181T + A209V;
A1 * + N2 * + L3V + M15T + R23K + S29A + A30E + Y31H + A33S + E34D + H35I + H156Y + A181T + N190F + A209V; or
A1 * + N2 * + L3V + M15T + R23K + S29A + A30E + Y31H + A33S + E34D + H35I + H156Y + A181T + N190F + A209V + Q264S.
H156Y+A181T+A209V;
H156Y+A181T+N190F+A209V+Q264S;
A1*+N2*+L3V+M15T+R23K+S29A+A30E+Y31H+A33S+E34D+H35I+H156Y+A181T+A209V;
A1*+N2*+L3V+M15T+R23K+S29A+A30E+Y31H+A33S+E34D+H35I+H156Y+A181T+N190F+A209V;
A1*+N2*+L3V+M15T+R23K+S29A+A30E+Y31H+A33S+E34D+H35I+H156Y+A181T+N190F+A209V+Q264S.2. The variant according to claim 1, showing increased stability at low pH and low concentration of Ca 2+ , relative to the maternal Termamyl-like α-amylase, and including mutations selected from the following
H156Y + A181T + A209V;
H156Y + A181T + N190F + A209V + Q264S;
A1 * + N2 * + L3V + M15T + R23K + S29A + A30E + Y31H + A33S + E34D + H35I + H156Y + A181T + A209V;
A1 * + N2 * + L3V + M15T + R23K + S29A + A30E + Y31H + A33S + E34D + H35I + H156Y + A181T + N190F + A209V;
A1 * + N2 * + L3V + M15T + R23K + S29A + A30E + Y31H + A33S + E34D + H35I + H156Y + A181T + N190F + A209V + Q264S.
α-амилазы В. licheniformis, обладающей последовательностью, показанной в SEQ ID No. 2,
α-амилазы В. amyloliquefaciens, обладающей последовательностью, показанной в SEQ ID No. 4,
α-амилазы В. stearothermophilus, обладающей последовательностью, показанной в SEQ ID No 6,
α-амилазы штаммы Bacillus NCIB 12512, обладающей последовательностью, показанной на фиг. 1 и 2,
α-амилазы штамма Bacillus NCIB 12513, обладающей последовательностью, показанной на фиг. 2, и
α-амилазы штамма Bacillus sp. #707, обладающей последовательностью, показанной на фиг. 2.3. The variant according to claim 1 or 2, characterized in that the maternal Termamyl-like α-amylase is selected from:
B. licheniformis α-amylase having the sequence shown in SEQ ID No. 2
B. amyloliquefaciens α-amylases having the sequence shown in SEQ ID No. 4,
B. stearothermophilus α-amylase having the sequence shown in SEQ ID No 6,
α-amylase strains of Bacillus NCIB 12512 having the sequence shown in FIG. 1 and 2,
α-amylases of Bacillus strain NCIB 12513 having the sequence shown in FIG. 2, and
α-amylase strain of Bacillus sp. # 707 having the sequence shown in FIG. 2.
(i) смесь из α-амилазы В. licheniformis, обладающей последовательностью, показанной в SEQ ID No. 2, и одним или несколькими вариантами, в соответствии с настоящим изобретением, полученными из (в качестве материнской Termamyl-подобной α-амилазы) α-амилазы В. stearothermophilus, обладающей последовательностью, показанной в SEQ ID No. 6; или
(ii) смесь из α-амилазы В. stearothermophilus, обладающей последовательностью, показанной в SEQ ID No. 6, и одним или несколькими вариантами, в соответствии с настоящим изобретением, полученными из одной или нескольких других материнских Termamyl-подобных α-амилаз; или
(iii) смесь из одного или нескольких вариантов, в соответствии с настоящим изобретением, полученными из (в качестве материнской Termamyl-подобной α-амилазы) α-амилазы В. stearothermophilus, обладающей последовательностью, показанной в SEQ ID No. 6, и одним или несколькими вариантами, в соответствии с настоящим изобретением, полученными из одной или нескольких материнских Termamyl-подобных α-амилаз.22. A composition comprising:
(i) a mixture of B. licheniformis α-amylase having the sequence shown in SEQ ID No. 2, and one or more variants, in accordance with the present invention, obtained from (as a maternal Termamyl-like α-amylase) α-amylase of B. stearothermophilus having the sequence shown in SEQ ID No. 6; or
(ii) a mixture of B. stearothermophilus α-amylase having the sequence shown in SEQ ID No. 6, and one or more variants, in accordance with the present invention, obtained from one or more other maternal Termamyl-like α-amylases; or
(iii) a mixture of one or more variants, in accordance with the present invention, obtained from (as a maternal Termamyl-like α-amylase) α-amylase of B. stearothermophilus having the sequence shown in SEQ ID No. 6, and one or more variants, in accordance with the present invention, obtained from one or more maternal Termamyl-like α-amylases.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK0515/96 | 1996-04-30 | ||
DK0712/96 | 1996-06-28 | ||
DK0775/96 | 1996-07-11 | ||
DK1263/96 | 1996-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU98121428A true RU98121428A (en) | 2000-09-20 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2305191A1 (en) | .alpha.-amylase mutants | |
US5763385A (en) | Modified α-amylases having altered calcium binding properties | |
JP2002530072A5 (en) | ||
CA2702204C (en) | Alpha-amylase mutants with altered properties | |
RU2001129163A (en) | ALFA AMILASE OPTIONS | |
US7713723B1 (en) | Alpha-amylase mutants with altered properties | |
CN100419076C (en) | Method for disigning alpha-amylase mutants with predetermined properties | |
US6440716B1 (en) | α-amylase mutants | |
CA2350837A1 (en) | .alpha.-amylase variants | |
EP0867504A1 (en) | Oxidation-stable alpha-amylase | |
DE96900894T1 (en) | amylase | |
EP2302048A1 (en) | Variants with altered properties | |
Endo et al. | A novel alkaline endoglucanase from an alkaliphilic Bacillus isolate: enzymatic properties, and nucleotide and deduced amino acid sequences | |
CA2274806A1 (en) | H mutant alpha-amylase enzymes | |
JP2001509389A (en) | Mutant α-amylase having a disulfide bond | |
DK2184350T3 (en) | CELLULASES WITH IMPROVED THERMOSTABILITY | |
CN1222938A (en) | Modified 'alpha'-amylases having altered calcium binding properties | |
RU98121428A (en) | α-Amylase Mutants | |
NZ524303A (en) | Alpha amylase enzymes with increased stability | |
KR100770721B1 (en) | ?-amylase mutants |